Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...
Zacks Investment Research on MSN
Amgen (AMGN) upgraded to buy: What does it mean for the stock?
Investors might want to bet on Amgen (AMGN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most ...
By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...
Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate ...
If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...
Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...
By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...
Amgen recalls 934K bottles of Corlanor and Sensipar due to foreign material and manufacturing deviations, per FDA June 23 report.
View Amgen Inc. AMGN stock quote prices, financial information, real-time forecasts, and company news from CNN.
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...
Amgen (AMGN) stock is in focus as an expert panel of the European Medicines Agency recommends withdrawal of the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results